Improving care for vulnerable populations with skin diseases
Patient Oriented Research in Vulnerable Populations with Skin Disease
This study is looking to improve care for older adults and people from different racial and ethnic backgrounds who have skin diseases like Hidradenitis Suppurativa, while also training new researchers to help tackle these health challenges together.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10984710 on NIH RePORTER |
What this research studies
This research focuses on enhancing the treatment and care of vulnerable populations suffering from skin diseases, particularly the elderly and racial and ethnic minorities. It aims to gather and analyze data on conditions like Hidradenitis Suppurativa through both quantitative and qualitative methods. The project will also provide training for emerging researchers in areas such as machine learning and health disparities, ensuring a comprehensive approach to understanding and addressing these issues. By leveraging existing networks and collaborations, the research seeks to create a more equitable healthcare environment for affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research include elderly individuals and racial or ethnic minorities who are experiencing skin diseases, especially Hidradenitis Suppurativa.
Not a fit: Patients who do not have skin diseases or who do not belong to the targeted vulnerable populations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies and healthcare access for patients with skin diseases, particularly those from vulnerable populations.
How similar studies have performed: Previous research has shown success in addressing health disparities in dermatology, making this approach both relevant and promising.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Linos, Eleni — Stanford University
- Study coordinator: Linos, Eleni
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.